Literature DB >> 20214522

Pain management in multiple myeloma.

Pasquale Niscola1, Laura Scaramucci, Claudio Romani, Marco Giovannini, Andrea Tendas, Gregorio Brunetti, Claudio Cartoni, Roberto Palumbo, Gisella Vischini, Agostina Siniscalchi, Paolo de Fabritiis, Tommaso Caravita.   

Abstract

Pain is a prominent feature of multiple myeloma (MM) and may be caused by different underlying causes and mechanisms. Indeed, pain may be due to disease-related complications, iatrogenic causes or may be associated with other unrelated medical conditions. This symptom may be particularly devastating and can negatively affect the quality of life of the afflicted patients and their functional status. For most MM patients suffering from continuous nociceptive pain, the WHO's three-step analgesic ladder can provide adequate relief with oral options, although the high prevalence in MM patients of difficult-to-treat pains, such as pains due to skeletal mechanical instability or sustained by neuropathic mechanisms, makes the treatment approach a challenging concern. The management of pain in this setting requires a multidisciplinary approach integrating analgesics and causal interventions. This review focuses on the most common syndromes afflicting MM patients, attempting to provide an understanding of the underlying pain mechanisms and a discussion of the most commonly used treatment strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214522     DOI: 10.1586/era.10.5

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  6 in total

1.  Towards a better understanding of the relationship between side effects of analgesia and quality of life in patients with multiple myeloma.

Authors:  Pasquale Niscola; Agostina Siniscalchi; Andrea Tendas; Paolo de Fabritiis; Tommaso Caravita; Fabio Efficace
Journal:  Support Care Cancer       Date:  2015-08-04       Impact factor: 3.603

2.  Bone Pain Induced by Multiple Myeloma Is Reduced by Targeting V-ATPase and ASIC3.

Authors:  Masahiro Hiasa; Tatsuo Okui; Yohance M Allette; Matthew S Ripsch; Ge-Hong Sun-Wada; Hiroki Wakabayashi; G David Roodman; Fletcher A White; Toshiyuki Yoneda
Journal:  Cancer Res       Date:  2017-03-02       Impact factor: 12.701

3.  Pain in blood cancers.

Authors:  Pasquale Niscola; Andrea Tendas; Laura Scaramucci; Marco Giovannini; Vitaliana De Sanctis
Journal:  Indian J Palliat Care       Date:  2011-09

4.  The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.

Authors:  Madeline L O'Sullivan; Rebecca A Shelby; Caroline S Dorfman; Sarah A Kelleher; Hannah M Fisher; Krista A Rowe Nichols; Francis J Keefe; Anthony D Sung; Tamara J Somers
Journal:  Support Care Cancer       Date:  2017-11-09       Impact factor: 3.359

5.  Side effects of analgesia may significantly reduce quality of life in symptomatic multiple myeloma: a cross-sectional prevalence study.

Authors:  Sarah Sloot; Jason Boland; John A Snowden; Yousef Ezaydi; Andrea Foster; Alison Gethin; Tracy Green; Louise Chopra; Stans Verhagen; Kris Vissers; Yvonne Engels; Sam H Ahmedzai
Journal:  Support Care Cancer       Date:  2014-08-28       Impact factor: 3.603

6.  An mHealth Pain Coping Skills Training Intervention for Hematopoietic Stem Cell Transplantation Patients: Development and Pilot Randomized Controlled Trial.

Authors:  Tamara J Somers; Sarah A Kelleher; Caroline S Dorfman; Rebecca A Shelby; Hannah M Fisher; Krista Rowe Nichols; Keith M Sullivan; Nelson J Chao; Gregory P Samsa; Amy P Abernethy; Francis J Keefe
Journal:  JMIR Mhealth Uhealth       Date:  2018-03-19       Impact factor: 4.773

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.